Epidemiological Data Chronic Kidney Diseases in Estonia Annual Report 2012

Similar documents
Epidemiological Data Chronic Kidney Diseases in Estonia Annual Report 2011

TRENDS IN RENAL REPLACEMENT THERAPY IN BOSNIA AND HERZEGOVINA

Overview of the Activities of Estonian Pharmacies

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

CHAPTER 9. End Stage Kidney Disease in Aotearoa/New Zealand

VASCULAR ACCESS FOR HAEMODIALYSIS

Chapter 5 PAEDIATRIC RENAL REPLACEMENT THERAPY. Lee Ming Lee Lim Yam Ngo Lynster Liaw Susan Pee Wan Jazilah Wan Ismail Yap Yok Chin

Cardiovascular disease profile

Incidence of new patients starting RRT

Chapter 12. End Stage Kidney Disease in Indigenous Peoples of Australia and Aotearoa/New Zealand. ANZDATA Registry 39th Annual Report

ERA-EDTA Registry Annual Report 2001

CHAPTER 5. Paediatric Renal Replacement Therapy

Renal replacement therapy for patients with diabetes mellitus in Hong Kong

End Stage Kidney Disease Among Indigenous Peoples of Australia and New Zealand

. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less

New Zealand. Dialysis and Transplantation Audit

Psychiatric Treatment in Estonia. Andres Lehtmets Psychiatric Center of East Tallinn Central Hospital

Renal Transplant Registry Report 2008

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Stephen McDonald. Matthew Jose. Kylie Hurst INDIGENOUS 12-1

Dialysis and Transplantation Audit

KIDNEY DIALYSIS FOUNDATION ANNUAL REPORT PERITONEAL DIALYSIS PROGRAMME

CHAPTER 4 METHOD AND LOCATION OF DIALYSIS. Nancy Briggs Kylie Hurst Stephen McDonald Annual Report 35th Edition

CHAPTER 5. Haemodialysis. Kevan Polkinghorne Hannah Dent Aarti Gulyani Kylie Hurst Stephen McDonald

CHAPTER 2. Prevalence of Renal Replacement Therapy for End Stage Kidney Disease

Building a clinical service for children with CKD in a developing country

Scottish Renal Registry Annual Report 2016.

CHAPTER 6 PERITONEAL DIALYSIS. Neil Boudville. Hannah Dent. Stephen McDonald. Kylie Hurst. Philip Clayton Annual Report - 36th Edition

CKD Prevention Program Protocol

Dialysis Initiation and Optimal Vascular Access: Outcomes and Mortality

CHAPTER 6 PERITONEAL DIALYSIS. Fiona Brown Aarti Gulyani Stephen McDonald Kylie Hurst Annual Report 35th Edition

Chapter 2. Prevalence of End Stage Kidney Disease. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

World Congress of Nephrology, Mexico City

Overview of the Activities of Estonian Pharmacies

RENINE Annual Report 2015

Difference in practical dialysis therapy between East Asia and US/EU

ASF epidemiological situation in Estonia update. PAFF meeting Brussels Estonian Veterinary and Food Board 1

morbidity & mortality

National Surveillance System for Dialysis Centre and Dialysis Associated Diseases

CHAPTER 6 PERITONEAL DIALYSIS

Chapter 10. Cancer. ANZDATA gratefully acknowledges the contributions of the Cancer Working Group convened by Germaine Wong.

Report Finnish Registry for Kidney Diseases. PD n=364. In-center HD n=1408. Kidney transplantation n=2945. Home HD n=138

CHAPTER 12 END-STAGE KIDNEY DISEASE AMONG INDIGENOUS PEOPLES OF AUSTRALIA AND NEW ZEALAND. Matthew Jose Stephen McDonald Leonie Excell

You can sleep while I dialyze

Epidemiology of kidney diseases in children

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

United States Renal Data System (USRDS) International Data Collection Form

Epidemiology of CKD in Children

Characteristics of Patients Initializing Peritoneal Dialysis Treatment From 2007 to 2014 Analysis From Henan Peritoneal Dialysis Registry data

2008 Dialysis Facility Report

The UK Renal Registry collects national data about the causes and treatment of kidney failure.

Secular Trends in Cardiovascular Disease in Kidney Transplant Recipients: 1994 to 2009

Chapter 7: ESRD among Children, Adolescents, and Young Adults

Experiences of site visits to Estonian low threshold service centres - improving TB case-finding and infection control

BAPN 2016 Audit of dialysis access and complications in UK children

Oxford Kidney Unit What do my blood and dialysis results mean? Information for patients

Options in Renal Replacement Therapy: When, whom, which? Prof Dr. Serhan Tuğlular Marmara University Medical School Division of Nephrology

Your Health Survey. Forename: Surname: Renal Unit: Type of treatment: If HD, are you: Date of birth: Home Post Code: Date completed: NHS number:

The Impact of Fatigue on Daily Activity in People with Chronic Kidney Disease

ANNUAL REPORT The Norwegian Renal Registry. (Norsk Nefrologiregister)

Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012

New Treatments for ADPKD how close are we?

Chapter 10. Cancer. ANZDATA Registry 39th Annual Report. Data to 31-Dec-2015

Dialysis Mortality Regional Clinical Audit Report 2011

2011 Dialysis Facility Report

FIRST RENAL REPLACEMENT

Chapter 3: National Renal Review 2002: summary report on adult and paediatric renal services

Transplant First: Addressing inequality in access to Kidney Transplantation in the West Midlands

QQuickly take me up into the bright child of your mind. E.E. CUMMINGS, The Enormous Room

2011 Dialysis Facility Report SAMPLE Dialysis Facility State: XX Network: 99 CCN: SAMPLE Dialysis Facility Report SAMPLE

patients and 66% of peritoneal dialysis patients had a systolic blood pressure within the 90th percentile

RENINE year report 2016

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

New Zealand Nephrology Activity Report 2014

Diane Watson, RN, MSc, C Neph (C) APN, Nephrology, UHN

Report Finnish Registry for Kidney Diseases. Proportion of patients reaching treatment target (%) 100. Healthcare districts Regions

National Kidney and Urologic Diseases Information Clearinghouse (NKUDIC)

CARE FOR CHRONIC RENAL PATIENTS ROLE OF MULTIDISCIPLINARY APPROACH ÁGNES HARIS MD PHD, ST. MARGIT HOSPITAL, BUDAPEST BUDAPEST NEPHROLOGY SCHOOL, 2017

Improved survival of type 2 diabetic patients on renal replacement therapy in Finland

KIDNEY DIALYSIS FOUNDATION ANNUAL REPORT MEDICAL (P.D.)

2010 Dialysis Facility Report

17 th Annual Meeting of JSHDF, Sept 3-4, 2011

Access to needle and syringe exchange services in Estonia

Population-wide Chronic Kidney Disease Management Reducing the Incidence of Kidney Failure

5FM QFMUQ? AFGJB?Q FC PC?JJW GQ 5FM QCRQ FGK GL FGQ AMLQRCJJ?RGML?LB NSRQ RFC KC?QSPGLE PMB MD BGQR?LAC GL FGQ F?LB

AJNT. Original Article

Chapter IX. Pediatric End Stage Renal Disease. Incidence of Reported Pediatric ESRD

Takashi Yagisawa 1,2*, Makiko Mieno 1,3, Norio Yoshimura 1,4, Kenji Yuzawa 1,5 and Shiro Takahara 1,6

Palliative and End of Life Care in End Stage Renal Disease

USRDS UNITED STATES RENAL DATA SYSTEM

All Wales National Audit 2013 f ACKD. Anaemia of CKD. Chris Brown SWW Renal Unit. David Jackson Anke Hagemi North Wales Renal Unit 10/21/2013 1

Report Finnish Registry for Kidney Diseases. Number of patients at end of year y y. 5 9 y. 0 4 y

AJNT. Special Article. Renal Replacement Therapy in Sudan, Sarra Elamin 1*, Wafaa Obeid 2, Hasan Abu-Aisha 1. Abstract

2018 ASIAN PACIFIC CONGRESS OF NEPHROLOGY

Specialised renal services and QIPP

Chapter 8: ESRD Among Children, Adolescents, and Young Adults

Geriatric Nephrology. Murtener Tage

Home Hemodialysis or Transplantation of the Treatment of Choice for Elderly?

COST MANAGEMENT: HOW CONVENIENT IS HOME HEMODIALYSIS?

Efficacy and tolerability of oral Sucrosomial Iron in CKD patients with anemia. Ioannis Griveas, MD, PhD

Transcription:

Epidemiological Data Chronic Kidney Diseases in Estonia Annual Report 2012

Toimetaja: Mai Rosenberg Tartu Ülikooli Sisekliinik Puusepa 6, Tartu ISSN 2346-5689 Eesti Ülikoolide Kirjastus OÜ www.eyk.ee

Acknowledgments Retrospective renal replacement therapy (RRT) patient s data analysis were performed by Ülle Pechter 1 and Mai Rosenberg 1 The steering group would like to thank the staff at all the renal centres and units in Estonia for their kind help with RRT patient data collection. Contributions to the RRT report were performed by Elviira Seppet 1, Eino Sinimäe 1, Külli Kõlvald 1, Kristi Veermäe 1, Aleksander Lõhmus 1, Jaanus Kahu 1, Peeter Dmitriev 1, Merike Luman 2, Asta Auerbach 2, Maris Mandel 2, Kadri Lilienthal 2, Madis Ilmoja 3, Margit Muliin 3, Kristin Sepp 3, Evelin Seppet 3, Kadri Telling 3, Ljubov Piel 3, Ülle Toots 4, Aili Traat 4, Inga Vainumäe 4 1 Tartu University Hospital (TUH), Department of Internal Medicine, 2 North-Estonian Regional Hospital, Tallinn (NERH), 3 West-Tallinn Central Hospita (WTCH)l, 4 paediatricians from Tallinn and Tartu Children s Hospitals Mai Rosenberg Toimetaja 3

Contens I Introduction page 5 II Incidence of RRT page 7 III Incident patient diagnoses page 8 IV Prevalence of RRT page 9 V Prevalent data in nephrology centres and units page 10 VI Prevalent RRT patient s trends page 14 VII Prevalent patients demography page 17 VIII Prevalent RRT patient s diagnoses page 19 IX Kidney transplantation page 22 X Survival page 23 XI Anaemia and biochemical data page 24 4

I Introduction Estonia in brief Official name: Republic of Estonia Area 45 227 square km Population: - 1.342409 million (1 Jan 2007 est. by Statistics Estonia) - 1.340935 million (1 Jan 2008 est. by Statistics Estonia) - 1.340415 million (1 Jan 2009 est. by Statistics Estonia) - 1.340127 million (1 Jan 2010 est. by Statistics Estonia) - 1.340194 million (1 Jan 2011 est. by Statistics Estonia) - 1.339662 million (1 Jan 2012 est. by Statistics Estonia) The last official census was taken in 2011 Larger cities: Tallinn (pop. 400 292) Tartu (103 740) Narva (66 151) Kohtla-Järve (44 821) Pärnu (44 024) Medical Faculty: at Tartu University (1632) Renal replacement therapy (RRT) in Estonia. The collection of RRT patient s epidemiology data in Estonia is ongoing constantly from 1996 as a part of epidemiological research. The study has been approved by the Ethics Committee on Human Research of the Tartu University, Estonia (latest approval protocol from 2012). Aggregated RRT patient data were annually sent to ERA-EDTA registry. The RRT epidemiological report is based on individual and centre questionnaires. Data were obtained from all nephrology centres and units. 5

Centres of nephrology in Estonia (Figure 1, big red circles): 1) Tartu University Hospital, Department of Internal Medicine, Division of Nephrology with satellites (small white circles), transplantation at the Department of Surgery, Division of Urology and Transplantation. 2) North-Estonian Regional Hospital, Department of Internal Medicine, Division of Nephrology with satellites (small white circles). 3) West-Tallinn Central Hospital, Department of Internal Medicine, Division of Nephrology with satellites (small white circles). Haemodialysis units at regional hospitals (3 small red circles): East-Viru Regional Hospital, Kuressaare Hospital, Narva Hospital Private Haemodialysis units (8, big white circles): Pärnu, Narva, Viljandi, Rakvere, Paide, Haapsalu, Rakvere, Jõgeva, Keila Figure 1. Nephrology centres (big red circles), satellites (small white circles), HD units at regional hospitals (small red circles) and private HD units (big white circles). 6

II Incidence of RRT Table 1. Incidence of RRT 2007 2012 2007 2008 2009 2010 2011 2012 New RRT pts (day1) 136 88 74 100 87 107 New RRT pts (day91) 130 85 70 98 81 100 Incidence pmp (Day 1) 95,7 65,7 54,5 74 64 82,3 Gender Day 1 M 80 43 42 53 52 55 F 56 45 31 47 35 52 Mean age Day 1 M 54,5 52,2 61,9 55,96 59,8 57,5 F 59,4 53,8 59,0 59,0 58,0 62,2 Treatment HD 85 87 32 74 61 83 PD 50 49 41 25 25 22 KT 1 2 1 1 1 2 The incident numbers almost similar during last five years. There are more male patients among incident RRT patients. Mean age became higher. Penetration of peritoneal dialysis is only 22%. Number of patients per million population 120 100 80 60 40 20 0 Annual incidence per million population of new patients starting RRT 2007 2012 95,7 65,7 54,5 7 74 64 82,3 2007 2008 2009 2010 2011 2012 Year starting RRT Figure 2. Incidence trends: incidence has remained low during last six years.

III Incident patient diagnoses Diabetes and hypertension are leading causes of stage 5 CKD patients. Glomerulonephritis and pyelonephritis are the next most common diagnosis among new RRT patients (Fig. 3 A and B). A 35 30 25 20 15 10 5 0 B Diagnosis of patients starting RRT (%) 2007 2008 2009 2010 2011 2012 Percentage of patients in each diagnosis group incidence at day 1 % of patients 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 2007 2008 2009 2010 2011 2012 Year starting RRT GN PN DM HYP PKD Other AMY Figure 3. A and B. Percentage of patients in each diagnosis group starting RRT 2007 2012 8

IV Prevalence of RRT Table 2. RRT patients total numbers and prevalence per million population according to treatment modality. Prevalence per million (nr) pmp (%) Total number of pt-s HD 195 35 257 PD 32 6 42 KT 329 59 434 RRT 552 100% 733 Number of patients 800 700 600 500 400 300 200 100 0 RRT trends in Estonia 2000 2012 according to modality of treatment 296 293 321 348 393 398 405 434 78 86 70 76 69 42 73 161 190 214 227 259 69 74 74 82 95 99 128 128 148 183 196 212 206 237 240 257 36 47 58 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 TX PD HD Figure 4. Prevalent patient s total numbers have stayed almost similar during three last years 2010-2012 9

V Prevalent data in nephrology centres and units Table 3. Prevalent RRT patients 2007 2011 according to centres and units HD 2007 2008 2009 2010 2011 2012 TU Hospital 22 34 37 41 27 28 WTCH 67 70 71 79 88 91 NERH 34 24 30 50 43 40 Children s Hospital 1 0 0 0 0 0 HD cabinets 73 84 67 67 82 81 Sum 197 212 205 237 240 252 PD 2007 2008 2009 2010 2011 2012 TU Hospital 39 26 32 41 30 17 WTCH 22 20 17 17 24 11 NERH 23 24 22 16 12 9 Children s Hospital 1 2 2 2 1 1 HD cabinets 0 0 0 0 2 1 Sum 85 72 73 76 69 39 KT 2007 2008 2009 2010 2011 2012 TU Hospital 134 144 160 158 153 159 WTCH 151 158 174 174 172 185 NERH 36 46 58 65 75 84 Children s Hospital 0 1 0 1 3 3 HD cabinets 0 0 0 0 2 5 Sum 321 349 392 398 405 435 All 2007 2008 2009 2010 2011 2012 TU Hospital 195 204 229 240 210 204 WTCH 240 248 262 270 284 287 NERH 93 94 110 131 130 145 Children s Hospital 2 3 2 3 4 2 HD cabinets 73 84 67 67 86 93 Sum 603 633 670 711 714 733 10

HD units 2007 2008 2009 2010 2011 2012 IVKH 11 12 7 7 8 8 Narva/Narva Hospital 12 / 1 11 / 5 10 / 4 10 / 6 11 / 7 9 Kuressaare 6 8 9 8 6 8 Rapla 4 Rakvere 7 9 3 5 4 10 Paide 1 2 2 1 4 4 Pärnu 12 17 15 12 14 20 Haapsalu 4 4 1 1 6 10 Viljandi 9 11 8 8 7 8 Võru 3 2 2 3 9 8 Valga 2 1 4 1 2 Jõgeva 5 5 4 4 6 5 Keila 0 3 2 1 2 2 Sum 79 350 300 250 200 150 100 50 0 RRT pts in kidney centers 2007 2008 2009 2010 2011 2012 TU Hospital WTCH NERH Childrens Hospital HD units Figure 5. Prevalent RRT patients in centres and units during 2007 2012 11

A 100 90 80 70 60 50 40 30 20 10 0 HD pts in kidney centers 2007 2008 2009 2010 2011 2012 B 45 40 35 30 25 20 15 10 5 0 PT pts in kidney centers 2007 2008 2009 2010 2011 2012 TU Hospital WTCH NERH Childrens Hospital HD units 12

C 200 180 160 140 120 100 80 60 40 20 0 1 2 3 4 5 6 TU Hospital WTCH NERH Childrens Hospital Figure 6. A, B, C, prevalent HD, PD and kidney transplant patients in different centres and units during 2007 2012 13

VI Prevalent RRT patient s trends Table 4. Prevalence of RRT trends in Estonia 2000 2012 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 RRT pts nr 279 332 371 424 461 528 554 603 630 672 711 714 733 Increase 7.3% 18.7% 11.7% 14.3% 8.7% 13.0% 6.3% 8.8% 4.5% 6.7% 5.8% 0.4% 2.7% RRT prevalence pmp 193 245 274 314 342 384 392 449 470 498 530 536 552 Dialysis pts no 118 142 157 197 202 225 261 282 282 279 313 309 299 HD 82 95 99 128 128 148 183 196 212 206 237 240 257 PD 36 47 58 69 74 74 78 86 70 73 76 69 42 KT 161 190 214 227 259 296 293 321 348 393 398 405 434 KT (%) 57.7% 57.2% 57.7% 53.5% 56.2% 56.8% 52.9% 53.2% 55.2% 58.5% 56.0% 56.7% 59.2% 14

Prevalent RRT patients increase 20% 18,7% 15% 14,3% 13,0% 10% 5% 0% 11,7% 8,8% 7,3% 8,7% 6,7% 5,8% 6,3% 4,5% 2,7% 0,4% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Figure 7. Prevalent RRT pts increase became lower during last ten years. This means that the beside the increasing of RRT population the annual growth is not any more so high compared with the beginning of the century. However, the increase of RRT prevalence was only 0.4% in 2011 and 2.7% in2012. 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 KT pts Dialysis pts Figure 8. Kidney transplantation patients have formed more than 50% from all RRT patients during 1996-2012 15

500 450 400 350 300 250 200 150 100 50 0 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 Dialysis pts Kidney transplant pts Figure 9. RRT trends in Estonia 1996 2012 according to modality of treatment. Number of patients 350 300 250 200 150 100 50 0 Dialysis trends in Estonia 2000 2012 76 69 42 86 70 73 78 74 69 74 47 58 183 196 212 237 240 206 257 36 128 128 148 82 95 99 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 PD HD Figure 10. Hemo- and peritoneal dialysis trends in Estonia. The figure shows that peritoneal dialysis pts population diminishes during last years. 16

VII Prevalent patients demography Table 5. Demographic data of prevalent RRT patients 2007 2008 2009 2010 2011 2012 M F M F M F M F M F M F HD 110 86 113 99 112 94 139 98 143 97 140 117 PD 48 38 40 30 37 36 40 36 35 34 20 23 KT 185 136 204 144 235 158 228 170 234 171 250 184 RRT pts 343 260 357 273 384 288 407 304 412 302 410 324 A Prevalent RRT population 2011 Patients 0 20 40 60 80 100 120 0-14 15-24 25-34 Age 35-44 45-54 55-64 65-74 75 and older Female Male 17

B Prevalent RRT population 2012 Patients 0 20 40 60 80 100 120 0-14 15-24 25-34 Age 35-44 45-54 55-64 65-74 75 and older Female Male Figure 11. Prevalent RRT population in different age groups in Estonia in 2011 and 2012 18

VIII Prevalent RRT patient s diagnoses Diagnoses of prevalent RRT patients Table 6. Number and percentage of pt in each diagnosis group according to treatment mode 2012 HD nr HD % PD nr PD % Transplant nr Transplant % Glomerulonephritis 36 17.5 6 8.2 149 37.9 Hypertension 47 22.8 18 24.7 27 6.8 IDDM 14 6.8 11 15.1 68 17.3 NIDDM 20 9.7 13 17.8 9 2.3 PCKD 13 6.3 3 4.1 44 11.2 Pyelonephritis 44 21.4 12 16.4 72 18.3 Other diagnoses 32 15.5 10 13.7 24 6.1 35 30 25 20 15 10 5 0 2000 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 GN PN DM HYP PKD Other AMY Figure 12. Percentage of patients in each diagnosis group receiving RRT 2000 2012. The most common kidney diagnosis of RRT patients was glomerulonephritis with ~30%. Diabetes was the second most common diagnosis instead of pyelonephritis that remained to the third place from 2003. 19

Table 7. Percentage of patients in each diagnosis group % 2000 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 GN 30.2 28.9 31.9 31 28 33 31.3 29.7 28.3 27.8 27.3 26.7 PN 20.2 18.6 18.8 20 20 18 19.9 19 19.2 18.9 17.4 17.8 DM 17.1 18.5 18.9 20 21 23 19.8 19.6 19.9 19.9 19.7 19.9 HYP 5.4 12.9 12.2 15 15 10 11.5 13.3 13.6 15.3 16.4 17.1 PKD 8 7 8 8 7 7 7.9 9.2 9 8.6 8.3 9.1 Other 13 8 4 5 5 4 7 6 9.8 9.5 10.9 10.5 AMY 6 6 6 4 3 4 2.5 3 2.9 2.9 2.5 2.3 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Percentage of patients in each diagnosis group 2000 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 GN PN DM HYP PKD Other AMY Figure 13. Percentage of patients in each diagnosis group. 20

A % of diagnosis 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Percentage of prevalent patients diagnosis in each treathment model in 2011 HD PD TX Treatment B % of diagnosis 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% Treatment mode and diagnosis 2012 HD PD TX Treatment GN PN DM HYP PKD Muu Figure 14. Prevalent patient diagnoses in each RRT patient s group A) 2011 and B) 2012. 21

IX Kidney transplantation 70 60 50 40 30 20 10 0 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 KT number Living donor KT pmp Figure 15. Kidney transplantation total numbers and transplantation number per million in Estonia during 2000-2012 22

X Survival Kaplan-Meier survival curve 1.0 0.8 Survival probability 0.6 0.4 0.2 HD PD TX 0.0 0 1 2 3 4 5 time(years) Figure 16. 5-year survival of haemodialysis, peritoneal dialysis and kidney transplant patients. The start date for the survival analyses is the first date of RRT. The end date is the date of death or the censor date of 31 December 2012 23

XI Anaemia and biochemical data Table 8. Anaemia and biochemical measures mean data (2011) in RRT patients groups. Peritoneal Haemodialysis Kidney transplant patients dialysis patients patients Hb(g/l) mean ± SD 112.0 ± 12.20 114.0 ± 13.90 125.0 ± 15.10 CRP (mg/l) mean ± SD 11.9 ± 20.0 11.3 ± 25.9 4.1 ± 6.7 Albumin (g/l) mean ± SD 38.5 ± 5.10 35.1 ± 4.3 42.4 ± 4.70 Cholesterol (mmol/l) mean ± SD 4.6 ± 1.1 5.9 ± 1.6 5.6 ± 1.3 PTH (pmol/l) mean ± SD 35.4 ± 39.9 29.5 ± 29.9 17.2 ± 15.2 ica (mmol/l) mean ± SD 1.17 ± 0.10 1.14 ± 0.10 1.29 ± 0.20 Alb-corrected Ca (mmol/l) mean ± SD 2.59 ± 0.30 2.48 ± 0.20 2.39 ± 0.30 P (mmol/l) mean ± SD 1.78 ± 0.60 1.87 ± 1.50 1.18 ± 0.40 24